Trembinski, D. Julia
Bink, Diewertje I.
Theodorou, Kosta
Sommer, Janina
Fischer, Ariane
van Bergen, Anke http://orcid.org/0000-0002-1843-5657
Kuo, Chao-Chung http://orcid.org/0000-0001-8879-4754
Costa, Ivan G. http://orcid.org/0000-0003-2890-8697
Schürmann, Christoph
Leisegang, Matthias S. http://orcid.org/0000-0002-6084-6484
Brandes, Ralf P. http://orcid.org/0000-0002-8035-0048
Alekseeva, Tijna
Brill, Boris
Wietelmann, Astrid
Johnson, Christopher N.
Spring-Connell, Alexander
Kaulich, Manuel http://orcid.org/0000-0002-9528-8822
Werfel, Stanislas
Engelhardt, Stefan http://orcid.org/0000-0001-5378-8661
Hirt, Marc N.
Yorgan, Kaja
Eschenhagen, Thomas http://orcid.org/0000-0003-1750-1170
Kirchhof, Luisa
Hofmann, Patrick
Jaé, Nicolas
Wittig, Ilka
Hamdani, Nazha
Bischof, Corinne
Krishnan, Jaya
Houtkooper, Riekelt H.
Dimmeler, Stefanie
Boon, Reinier A. http://orcid.org/0000-0001-7944-9748
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB815, SFB834, SFB834)
Article History
Received: 10 August 2018
Accepted: 7 April 2020
First Online: 27 April 2020
Competing interests
: D.J.T., R.A.B., and S.D. have filed a patent about the therapeutic use of the lncRNA <i>Sarrah</i>. The remaining authors declare no competing interests.